884600-93-5

Basic information

• Product Name: Benzamide, 3-iodo-4-methyl-N-[3-(trifluoromethyl)phenyl]-
• CAS NO: 884600-93-5
• Molecular Formula: C15H11F3INO
• Molecular Weight: 405.158
• Mol File: 884600-93-5.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzamide, 3-iodo-4-methyl-N-[3-(trifluoromethyl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 3-iodo-4-methyl-N-[3-(trifluoromethyl)phenyl]-(884600-93-5)
• EPA Substance Registry System: Benzamide, 3-iodo-4-methyl-N-[3-(trifluoromethyl)phenyl]-(884600-93-5)

Safety Data

• Hazardous Substances Data: 884600-93-5(Hazardous Substances Data)

Upstream product

• 82998-57-0 3-iodo-4-toluic acid 
• 98-16-8 3-trifluoromethylaniline 
• 52107-98-9 3-iodo-4-methylbenzoyl chloride 

Downstream Products

• 926036-39-7 3-ethynyl-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide 
• 882678-81-1 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-N-(3-(trifluoromethyl)phenyl)benzamide 
• 1036376-96-1 6-methyl-4'-nitro-N-[3-(trifluoromethyl)phenyl]biphenyl-3-carboxamide 
• 1036377-14-6 6-methyl-3'-nitro-N-[3-(trifluoromethyl)phenyl]biphenyl-3-carboxamide 
• 1018070-64-8 methyl 2-methyl-5-((3-(trifluoromethyl)phenyl)carbamoyl)benzoate 
• 1018069-85-6 2-methyl-5-((3-(trifluoromethyl)phenyl)carbamoyl)benzoic acid 
• 1431727-36-4 N³-(2-(3-aminophenylamino)pyrimidin-5-yl)-4-methyl-N₁-(3-(trifluoromethyl)phenyl)isophthalamide 
• 1232836-29-1 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide 

Relevant articles and documents

Inhibitor of Bruton tyrosine kinase

The invention discloses a compound of a formula (I) with Btk inhibiting activity, wherein all variables are as defined in the description. The compound can be used for treating autoimmune diseases, heteroimmune diseases, cancers or thrombembolia. The inve

DERIVATIVES OF 1 H-PYRAZOLO[3,4-B]PYRIDINE AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

The present invention discloses compounds according to Formula (I): wherein R1, R2, R3, R4, L, and X are as defined herein. The present invention relates to compounds,methods for their production, pharmaceutical

SUBSTITUTED HETEROCYCLES AS JANUS KINASE INHIBITORS

The present invention provides substituted tricyclic heteroaryl compounds, including, for example, pyridoindoles, pyrimidinoindoles and triazinoindoles that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases such as immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.